Fig. 4

Radiomics-clinical nomogram developed in the training set, incorporating the radiomics signature, CA19-9, and CT-reported regional LN status. CA19-9, carbohydrate antigen 19–9; LN, lymph node
Radiomics-clinical nomogram developed in the training set, incorporating the radiomics signature, CA19-9, and CT-reported regional LN status. CA19-9, carbohydrate antigen 19–9; LN, lymph node